Can Synthroid Cause High Blood Pressure?

Synthroid (levothyroxine) at the correct replacement dose does not cause high blood pressure and, in most people, actually lowers it. The drug replaces thyroid hormone that your body is not making enough of, and untreated hypothyroidism is itself a known cause of elevated blood pressure. Two large meta-analyses have found that levothyroxine therapy reduces both systolic and diastolic readings in patients with underactive thyroids. The scenario where the medication could push blood pressure upward is real but specific: it involves taking too much, not the drug itself.

How an Underactive Thyroid Raises Blood Pressure

Both overt and mild (subclinical) hypothyroidism can cause elevated blood pressure, though the mechanisms are not completely mapped out. Thyroid hormones directly affect how blood vessels relax and how the heart pumps. When thyroid levels drop, blood vessels tend to stiffen and peripheral resistance rises. The heart compensates by squeezing harder against that resistance, which drives diastolic pressure up in particular. This is why hypothyroid patients often show a pattern of modestly elevated diastolic readings rather than the classic systolic spike seen in other forms of hypertension.

A landmark study in the journal Hypertension found that when hypothyroid patients were restored to normal thyroid levels with thyroxine replacement, diastolic blood pressure fell below 90 mmHg in a meaningful share of patients, even after their blood pressure medications had been withdrawn.¹ In other words, some people who appeared to have primary hypertension actually had “hypothyroid hypertension” that resolved once the thyroid problem was treated. The implication is straightforward: if your blood pressure went up around the same time your thyroid slowed down, levothyroxine treatment may bring it back down rather than push it higher.

What the Meta-Analyses Show

The strongest evidence comes from systematic reviews that pool data across many studies. A meta-analysis of 10 randomized controlled trials found that levothyroxine therapy reduced systolic blood pressure by roughly 2.5 mmHg in patients with subclinical hypothyroidism. When the authors also looked at 19 prospective follow-up studies (where patients served as their own controls, measured before and after treatment), the drops were larger: about 4.8 mmHg for systolic and 2.7 mmHg for diastolic blood pressure.²

A separate, more recent meta-analysis that included 28 prospective cohort studies confirmed this direction, finding levothyroxine significantly lowered both systolic and diastolic pressures in subclinical hypothyroidism. The randomized trial data in that analysis did not reach statistical significance on its own, but the overall trend was consistent: treatment either lowered blood pressure or left it unchanged.³

These are not dramatic drops, but they are clinically meaningful, especially if you consider that the patients studied had only mildly underactive thyroids. People with more severe hypothyroidism may see bigger improvements. One study of 30 patients with both hypertension and hypothyroidism found that half of them experienced complete normalization of blood pressure with levothyroxine alone, while the other half still saw a modest decrease.⁴

When the Dose Is Too High

The situation flips when you are getting more levothyroxine than your body needs. Over-replacement pushes your system into a state that mimics hyperthyroidism: your metabolism speeds up, your heart rate climbs, and your cardiovascular system works harder. A systematic review of levothyroxine overdose cases found that the most common symptoms were rapid heart rate, confusion, and fever. Patients who took intentionally high doses had significantly higher diastolic blood pressure compared with accidental cases.⁵

You do not need to swallow a bottle of pills to experience over-replacement. It can happen gradually if your dose is not adjusted after weight loss, after menopause, as you age, or if a medication interaction changes how much levothyroxine your gut absorbs. Symptoms of mild over-replacement can be subtle: feeling jittery, sleeping poorly, a heart rate that sits a few beats higher than usual. Blood pressure may creep up during this window without an obvious cause. If your TSH test comes back suppressed (below the normal range), that is a sign you may be over-replaced, and your prescriber will typically reduce the dose.

TSH Suppression Therapy After Thyroid Cancer

There is one population that takes levothyroxine at deliberately high doses: people treated for differentiated thyroid cancer. After surgery, many of these patients are kept on doses high enough to suppress TSH to near-zero levels, which is thought to reduce the risk of cancer recurrence. This is a fundamentally different situation from standard replacement therapy.

A meta-analysis of TSH suppression therapy found that these patients had higher average systolic blood pressure (roughly 2 mmHg) and diastolic blood pressure (roughly 1.9 mmHg) compared with controls, though the differences were not statistically significant in all analyses.⁶ A separate review noted that the cardiovascular risks of long-term suppression include increased heart rate, greater left ventricular mass, and a higher chance of atrial fibrillation, particularly in older patients or those with preexisting heart disease.⁷

A study specifically measuring heart changes found that long-term thyroxine at TSH-suppressive doses had no detectable effect on blood pressure or heart rate per se but was associated with an 18% increase in left ventricular mass, meaning the heart muscle thickened.⁸ Over time, a thickened heart can contribute to blood pressure problems. Oncologists and endocrinologists weigh these risks against cancer recurrence risk, and many guidelines now recommend less aggressive suppression in low-risk patients.

Stable Replacement Doses and Long-Term Vascular Health

If your dose is properly calibrated and your TSH sits in the normal range, the evidence suggests that long-term levothyroxine does not stiffen your arteries or raise your central blood pressure. A study comparing thyroidectomized patients on stable replacement therapy with healthy controls found no differences in central systolic or diastolic blood pressure, arterial stiffness (measured by pulse wave velocity), or other vascular markers.⁹ This is reassuring for people who worry about taking the medication for decades.

Similarly, an observational study following about 400 patients over roughly nine years found no increased risk of cardiovascular disease, atrial fibrillation, or fractures in those taking levothyroxine compared with those who were not, after adjusting for age.¹⁰ The long-term cardiovascular safety profile of properly dosed Synthroid appears solid.

Why Older Adults Need Extra Caution

The typical starting dose for levothyroxine in a younger adult might be 50 to 100 micrograms, but in older adults, particularly those with known heart disease, clinicians usually start much lower and increase slowly. The reason: an abrupt rise in thyroid hormone can increase the heart’s workload and oxygen demand, which can worsen angina or precipitate heart rhythm problems in someone whose coronary arteries are already narrowed.

A review focused on elderly patients emphasized that the maintenance dose often needs to remain lower than in younger patients, with thyroid levels checked at individually tailored intervals. Over-treatment in this group carries particular risks, including cardiac events, osteoporosis, and cognitive decline.¹¹ If you are over 65 and notice palpitations, chest tightness, or a jump in blood pressure readings after starting or increasing Synthroid, those are signals to bring up with your doctor promptly.

Absorption Problems That Mimic Dose Changes

Even if your prescribed dose stays the same on paper, the amount of levothyroxine that actually gets into your bloodstream can fluctuate. This matters for blood pressure because erratic absorption can swing you between under-replaced and over-replaced states without anyone changing a pill.

The most common culprits are calcium supplements, iron supplements, and certain acid-reducing medications, all of which bind levothyroxine in the gut and reduce how much you absorb. A systematic review found that calcium carbonate taken alongside levothyroxine impaired not just thyroid hormone levels but also blood pressure control, cholesterol, and blood sugar. Switching to a liquid or softgel formulation of levothyroxine, which is less affected by these interactions, improved blood pressure readings in postmenopausal women who needed both medications.¹²

Coffee, soy products, and fiber supplements can also interfere with absorption if taken at the same time. The standard recommendation is to take levothyroxine on an empty stomach, 30 to 60 minutes before food, and to separate it from calcium or iron by at least four hours. If your blood pressure has been fluctuating and you recently started any of these supplements or changed when you eat breakfast, the absorption angle is worth considering before assuming the Synthroid itself is the problem.

Pregnancy, Levothyroxine, and Blood Pressure

Pregnant women with hypothyroidism take levothyroxine to protect both their own health and the baby’s brain development, and their dose needs typically rise during pregnancy. There has been some concern about whether levothyroxine use is associated with preeclampsia, the dangerous pregnancy-related blood pressure condition.

One study found a statistically significant association between levothyroxine use and preeclampsia, with an odds ratio of about 1.5, meaning the risk appeared roughly 50% higher among women on the medication. The authors noted that coexisting health conditions likely explained much of this link.¹³ But a more recent meta-analysis looking specifically at whether levothyroxine treatment changes the odds of gestational hypertension or preeclampsia found no increased risk in women with subclinical or overt hypothyroidism who were treated compared with controls. For women with thyroid autoimmunity (positive TPO antibodies), levothyroxine actually cut the risk of gestational hypertension significantly.¹⁴

A separate study of pregnant women with subclinical hypothyroidism found no correlation between levothyroxine dosage and either systolic or diastolic blood pressure.¹⁵ The picture that emerges is that the earlier single-study finding likely reflected the underlying thyroid disease and comorbidities rather than the medication. If anything, treating the thyroid problem in pregnancy appears protective against hypertensive complications for some women.

A Genetic Wrinkle That Affects Some People

Your body does not use levothyroxine (T4) directly. It converts it into the active form (T3) using enzymes, one of the most important being type 2 deiodinase (DIO2). A common genetic variant in the DIO2 gene, called Thr92Ala, may influence how well this conversion happens in your blood vessels and other tissues.

A study of euthyroid adults found that carriers of the Ala92 version of this gene were about twice as likely to develop hypertension compared to those without the variant, with an odds ratio of roughly 2.1 after adjusting for age, sex, and race.¹⁶ A larger Korean population study confirmed that hypothyroid patients carrying this DIO2 variant had a higher incidence of developing hypertension over time, and gene expression analysis suggested the variant affects blood vessel regulation.¹⁷

A smaller clinical study also found a connection between a DIO2 variant and both systolic and diastolic blood pressure in hypothyroid patients on levothyroxine, though it did not affect the dose of medication they needed.¹⁸ This is still an emerging area, and genetic testing for DIO2 variants is not routine. But it may explain why a subset of hypothyroid patients on levothyroxine still struggle with blood pressure even when their TSH looks normal on paper: their tissues may not be converting T4 to T3 efficiently where it counts.

The Rare Adrenal Interaction

There is one uncommon but dangerous scenario worth knowing about. If someone has undiagnosed adrenal insufficiency (their adrenal glands do not produce enough cortisol) and they start levothyroxine, the medication can precipitate an adrenal crisis. This is essentially the opposite of the high blood pressure concern: the patient’s blood pressure crashes dangerously, along with blood sugar. A case report described a 31-year-old man who developed severe hypotension and went into cardiac arrest shortly after starting levothyroxine for a new hypothyroidism diagnosis, because his adrenal insufficiency had not been recognized.¹⁹

This happens because thyroid hormone speeds up the body’s clearance of cortisol. If cortisol is already dangerously low, ramping up thyroid function can tip the balance. Clinicians are taught to check for adrenal insufficiency before starting thyroid replacement, especially when both conditions are suspected (a combination seen in autoimmune polyendocrine syndromes). The practical takeaway for patients is that severe fatigue, unexplained weight loss, dizziness, and nausea after starting levothyroxine are not typical adjustment symptoms and warrant urgent medical evaluation.